HALISTER: Novartis Considers Up to $5 Billion Deals in Cancer, Generics

Novartis Considers Up to $5 Billion Deals in Cancer, Generics

Alert: HALISTER
Source: BN (Bloomberg News)

Tickers
NOVN VX (Novartis AG)

People
Joseph Jimenez (Novartis AG)

Topics
CEO Interviews

To de-activate this alert, click here
To modify this alert, click here

UUID: 7947283